Yili Chuannig Biotechnology Co Ltd

SZSE:301301 (China)   Ordinary Shares Class A
Â¥ 13.09 (-1.28%) Jun 7
26.18
P/B:
3.98
Market Cap:
Â¥ 29.15B ($ 4.02B)
Enterprise V:
Â¥ 30.17B ($ 4.16B)
Volume:
43.86M
Avg Vol (2M):
67.75M
Volume:
43.86M
PE Ratio PS Ratio PB Ratio Price-to-FCF Market Cap
Current and historical daily PE Ratio for Yili Chuannig Biotechnology Co Ltd ( SZSE:301301 ) from 2022 to Jun 10 2024. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The PE ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the PE ratio is positive. Also for stocks with the same PE ratio, the one with faster growth business is more attractive. Yili Chuannig Biotechnology stock (SZSE:301301) PE ratio as of Jun 10 2024 is 26.18. More Details

Yili Chuannig Biotechnology Co Ltd (SZSE:301301) PE Ratio (TTM) Chart

To

Yili Chuannig Biotechnology Co Ltd (SZSE:301301) PE Ratio (TTM) Historical Data

Total 349
  • 1
  • 2
  • 3
  • 4
Yili Chuannig Biotechnology PE Ratio (TTM) Historical Data
Date PE Ratio (TTM) Data Date PE Ratio (TTM) Data
2024-06-10 26.2 2024-04-01 19.1
2024-06-07 26.2 2024-03-29 18.4
2024-06-06 26.5 2024-03-28 18.6
2024-06-05 27.2 2024-03-27 22.1
2024-06-04 27.2 2024-03-26 22.2
2024-06-03 26.6 2024-03-25 22.2
2024-05-31 26.6 2024-03-22 22.3
2024-05-30 26.5 2024-03-21 22.8
2024-05-29 27.4 2024-03-20 22.9
2024-05-28 27.4 2024-03-19 23.1
2024-05-27 27.5 2024-03-18 23.0
2024-05-24 27.9 2024-03-15 22.8
2024-05-23 28.4 2024-03-14 22.6
2024-05-22 29.3 2024-03-13 22.4
2024-05-21 30.5 2024-03-12 22.5
2024-05-20 31.0 2024-03-11 22.6
2024-05-17 31.3 2024-03-08 22.6
2024-05-16 31.0 2024-03-07 22.2
2024-05-15 31.8 2024-03-06 22.8
2024-05-14 34.0 2024-03-05 22.6
2024-05-13 33.3 2024-03-04 22.7
2024-05-10 33.8 2024-03-01 22.2
2024-05-09 35.0 2024-02-29 22.1
2024-05-08 35.5 2024-02-28 21.2
2024-05-07 33.9 2024-02-27 22.1
2024-05-06 31.6 2024-02-26 21.6
2024-04-30 26.4 2024-02-23 21.9
2024-04-29 22.0 2024-02-22 20.8
2024-04-26 19.6 2024-02-21 20.6
2024-04-25 19.6 2024-02-20 20.7
2024-04-24 18.8 2024-02-19 20.6
2024-04-23 18.5 2024-02-08 20.1
2024-04-22 18.8 2024-02-07 19.7
2024-04-19 18.8 2024-02-06 19.3
2024-04-18 18.6 2024-02-05 17.1
2024-04-17 19.1 2024-02-02 18.2
2024-04-16 18.7 2024-02-01 19.1
2024-04-15 18.6 2024-01-31 19.1
2024-04-12 18.7 2024-01-30 19.5
2024-04-11 19.7 2024-01-29 20.4
2024-04-10 18.5 2024-01-26 20.6
2024-04-09 18.8 2024-01-25 20.5
2024-04-08 18.5 2024-01-24 20.0
2024-04-03 19.0 2024-01-23 19.8
2024-04-02 19.2 2024-01-22 19.7

Yili Chuannig Biotechnology Co Ltd (SZSE:301301) PE Ratio (TTM) Comparison

Company Market Cap(Mil) PE Ratio (TTM)

Business Description

Business Description

Description
Yili Chuannig Biotechnology Co Ltd adopts the most advanced and mature international biological fermentation, chemical extraction, enzymatic hydrolysis, control and energy saving, and environmental protection technology. The main products of the company include erythromycin thiocyanate, cephalosporin intermediates, penicillin intermediates, and crude ursodeoxycholic acid.